The COMFORT Trials: What Is the Impact on Survival?

patientpower has 2408 videos Subscribe Here

Description: Dr. Claire Harrison, a leading MPN expert, provides an analysis of the COMFORT-I and COMFORT-II trials, which focus on evaluating the use of a JAK inhibitor, ruxolitinib, in treating people with myelofibrosis. Dr. Harrison explains how the studies shed new light on treatment safety and efficacy, while also revealing more about the drug's potential impact on quality of life and survival.
Shared By : patientpower
Posted on : 01/07/14
Added : 4 years ago
Category : General